ISRCTN17418767CompletedNot Applicable
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in the Sultanate of Oma
World Health Organization (WHO) (Switzerland)0 sites400 target enrollmentStarted: August 15, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Healthy Omani newborns (greater than 2.5 kg, apgar score greater than 9 at five minutes)
- •2. Living within the catchment area of the participating study site
- •3. Newborns delivered by caesarean section
Exclusion Criteria
- •1. Newborns requiring hospitalisation (except if in hospital because of maternal admission)
- •2. Birth weight below 2.5 kg
- •3. Apgar score less than 9 at five minutes
- •4. Non-Omani
- •5. Residence outside the catchment area, or families expecting to move away during the study period
- •6. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will also render the newborn ineligible for the study
Investigators
Similar Trials
Completed
Phase 4
Comparison of immune response of fractional doses, administered intradermally vs. full doses administered intramuscularly of inactivated poliovirus vaccine (IPV) in male adults in Camaguey, Cuba.PoliomyelitisInfection - Other infectious diseasesPublic Health - EpidemiologyACTRN12615000305527World Health Organization600
Active, not recruiting
Not Applicable
Trial to assess whether it is safe and efficient to vaccinate children with lower dose of Inactivated Poliovirus Vaccine (IPV) , Cuba 2017polioACTRN12617001525370WHO400
Active, not recruiting
Not Applicable
Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses IntramuscularlyPoliomyelitisEUCTR2015-005183-42-Outside-EU/EEASanofi Pasteur SA236
Completed
Not Applicable
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in CubaPoliomyelitis vaccinationInfections and InfestationsPoliomyelitisISRCTN19673867World Health Organization (WHO) (Switzerland)320
Not yet recruiting
Phase 3
Safety & Immunogenicity of Fractional Doses of Vaccines Among Nigerian Adults- A Randomised Non-Inferiority Triple Blind TrialCOVID -19PACTR202206754734018igeria Federal Ministry of health1,812
